Advaxis (NASDAQ: ADXS) announced that the Georgia Regents University (GRU) Cancer Center has received Institutional Review Board (IRB) approval to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE